Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Teresa Milner"'
Autor:
Amanda Linkous, Demosthenes Balamatsias, Matija Snuderl, Lincoln Edwards, Ken Miyaguchi, Teresa Milner, Batsheva Reich, Leona Cohen-Gould, Andrew Storaska, Yasumi Nakayama, Emily Schenkein, Richa Singhania, Stefano Cirigliano, Tarig Magdeldin, Ying Lin, Gouri Nanjangud, Kalyani Chadalavada, David Pisapia, Conor Liston, Howard A. Fine
Publikováno v:
Cell Reports, Vol 26, Iss 12, Pp 3203-3211.e5 (2019)
Summary: The prognosis of patients with glioblastoma (GBM) remains dismal, with a median survival of approximately 15 months. Current preclinical GBM models are limited by the lack of a “normal” human microenvironment and the inability of many tu
Externí odkaz:
https://doaj.org/article/f28ebd0f3f8540688e121a8ec45550af
Autor:
Joshua Epstein, John Crowley, Bart Barlogie, Klaus Hollmig, Elias Anaissie, Teresa Milner, Frits van Rhee, Guido Tricot, Erik Rasmussen, Maurizio Zangari, John D. Shaughnessy
Publikováno v:
Blood. 106:1153-1153
Background: The extension of overall survival (OS) in MM has been partly linked to increasing CR rates especially with high-dose melphalan. Data bases of TT1 and TT2 were examined to determine whether 5-yr Rc was key to prolonged OS. Patients and Met
Autor:
Joshua Epstein, Bart Barlogie, Guido Tricot, Maurizio Zangari, Frits van Rhee, Teresa Milner, Erik Rasmussen, Elias Anaissie, John D. Shaughnessy, Klaus Hollmig, John Crowley
Publikováno v:
Blood. 106:1152-1152
Background: TT2 introduced T into the frontline therapy for MM in a randomized phase III trial design (ASCO 2005). In comparison to TT1, TT2 applied: (1) more intensive chemotherapy for induction prior to and introduced CCT after melphalan 200mg/sqm-
Autor:
Guido Tricot, Bart Barlogie, Bart Burington, Joshua Epstein, John D. Shaughnessy, John Crowley, Teresa Milner, Maurizio Zangari, Ichiro Hanamura, Peter Stewart, Elias Anaissie, Klaus Hollmig, Erik Rasmussen, Frits van Rhee
Publikováno v:
Blood. 106:1155-1155
Background: T2 randomized 668 patients up-front to +/− T as part of an intensive combination chemotherapy program prior to and after melphalan-based tandem autotransplants (Barlogie, ASCO 2005). Patients randomized to T had superior 2-yr CR (52% vs
Autor:
Guido Tricot, Maureen Reiner, Bart Barlogie, Maurizio Zangari, Elias Anaissie, Frits van Rhee, Teresa Milner
Publikováno v:
Blood. 106:1157-1157
In acute leukemia and intermediate/high grade lymphoma it is important to achieve a CR as early as possible. The aim of the study was to evaluate if the same is true in myeloma treated with intensive therapy including tandem transplants (Tx-1; Tx-2).
Autor:
Choon-Kee Lee, Athanasios Fassas, Lisa Jackson, Frank Zhan, Teresa Milner, Bart Barlogie, John D. Shaughnessy, Giampaolo Talamo, John Crowley, Guido Tricot, Erik Rasmussen, Raymond Thertulien, Maurizio Zangari
Publikováno v:
Blood. 104:4935-4935
We have previously reported on the adverse prognostic implications m-CA, present in ~ 33% of newly diagnosed patients especially when involving del 13 (~ 20%). To overcome the proliferation dependency of m-CA, FISH has been applied detecting abnormal
Autor:
Bart Barlogie, Klaus Hollmig, John Crowley, Raymond Thertulien, Julie Stover, G. Talamo, Teresa Milner, Maurizio Zangari, Guido Tricot, Frits van Rhee, Athanasios Fassas, Elias Anaissie
Publikováno v:
Blood. 104:936-936
Between October 1998 and February 2004, a total of 668 recently diagnosed myeloma patients were enrolled in TT-2, of whom 566 completed the first and 417 the second autotransplant. Twenty percent of patients were ≥ 65 years of age and 34% had abnor